S32
Section 32 (S32) is a venture capital firm focused on investments at the intersection of life sciences, biotechnology, healthcare and technology. The firm provides capital and domain-focused support to its portfolio through a team of investment professionals and external advisors.
Services
Direct equity investments
Provides venture capital funding to private companies.
Strategic and operational guidance
Offers strategic advice and operational support to portfolio companies.
Scientific and technical advisory
Access to scientific and domain expertise via named advisors and internal team members.
Network and partnership access
Introductions to potential partners, customers, and follow-on investors through the firm's network.
Direct equity investments
Provides venture capital funding to private companies.
Strategic and operational guidance
Offers strategic advice and operational support to portfolio companies.
Scientific and technical advisory
Access to scientific and domain expertise via named advisors and internal team members.
Network and partnership access
Introductions to potential partners, customers, and follow-on investors through the firm's network.